Hi everyone - primer is right to question the information in the link. The presentation was made by puma biotechnics? who are I think the makers of neratinib. They quote the Hera trials which looked at impact of herceptin on women who had undergone neoadjuvant and adjuvant chemotherapy. Not sure if the herceptin was given after this or during. I am new to all of this and only up to lumpectomy axillary dissection and four a/c chemos. Start paclitaxl? And herceptin on 6 April. I do hope you are right primek and stats are better than those presented in the presentation. I am trying to be more informed as my breast surgeon did not mention neoadjuvant back in November and I just want herceptin to get to work as soon as possible. Hugs to all